AMICUS THERAPEUTICS INC. - COMMON STOCK
7.4600
26-August-25 08:00:17
15 minutes delayed
Stocks
-0.0200
-0.27%
Today's range
7.4000 - 7.5200
ISIN
N/A
Source
NASDAQ
-
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
28 Oct 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva
17 Oct 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024
04 Oct 2024 04:00:00 By Nasdaq GlobeNewswire
-
UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
03 Sep 2024 04:46:15 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
03 Sep 2024 04:05:20 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium
03 Sep 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
30 Aug 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates
08 Aug 2024 04:00:21 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024
30 Jul 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
05 Jun 2024 04:00:00 By Nasdaq GlobeNewswire
-
04 Jun 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
09 May 2024 04:00:01 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
08 May 2024 04:00:01 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
01 May 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
20 Mar 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
01 Mar 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
28 Feb 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
15 Feb 2024 04:00:00 By Nasdaq GlobeNewswire
-
08 Feb 2024 04:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024
01 Feb 2024 04:00:00 By Nasdaq GlobeNewswire